China approves its first homegrown coronavirus vaccine, developed by Sinopharm localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
China approves its first homegrown coronavirus vaccine, developed by Sinopharm
CNN
31st December, 2020 10:41:22
Chinese regulators have approved the country s first homegrown coronavirus vaccine, developed by state-owned pharmaceutical giant Sinopharm, officials announced Thursday.
The approval comes a day after Sinopharm said its vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials.
China has drastically scaled up its vaccine emergency use program in recent weeks. Since December 15, it has administered more than 3 million vaccine doses on key groups in the population, Zeng Yixin, vice-minister of China s National Health Commission, said at a news conference Thursday.
That s on top of the 1.5 million doses administered on high-risk groups by the end of November, Zeng added.
China approves Sinopharm Covid-19 vaccine, promises free shots for all citizens
China approved its first homegrown coronavirus vaccine for general public use on Thursday, with officials promising to provide the general public with free inoculations.
The approval comes a day after its manufacturer, state-owned pharmaceutical giant Sinopharm, said the vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials.
Though no detailed efficacy data for the vaccine has been released, the decision to grant approval underscores claims made by Chinese officials in recent weeks over the safety and effectiveness of the country’s domestically produced vaccine candidates.
China is aiming to inoculate 50 million people with domestic Covid-19 vaccines ahead of February’s Lunar New Year celebrations. It has also drastically scaled up its vaccine emergency use program in recent weeks.
China approves its first homegrown coronavirus vaccine developed by Sinopharm
By
Nectar Gan, CNN
Updated Dec 31, 2020 12:06:00 PM
enablePagination: false
endIndex:
(CNN) – Chinese regulators have approved the country s first homegrown coronavirus vaccine, developed by state-owned pharmaceutical giant Sinopharm, officials announced Thursday.
The approval comes a day after Sinopharm said its vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials.
China has drastically scaled up its vaccine emergency use program in recent weeks. Since December 15, it has administered more than 3 million vaccine doses on key groups in the population, Zeng Yixin, vice-minister of China s National Health Commission, said at a news conference Thursday.
China Has All It Needs to Vaccinate Millions, Except Any Approved Vaccines
Across the country, local governments plan to inoculate 50 million people against the coronavirus by early next year. But the vaccines have not officially been approved.
Sinovac, a private Beijing-based vaccine maker, has produced millions of doses of its vaccine but has yet to receive government approval. Credit.Thomas Peter/Reuters
Everything, that is, except much proof that their vaccines work.
Unlike their Western competitors, most Chinese companies have not disclosed data from late-stage clinical trials that would show whether their vaccines are effective; just one, the state-owned Sinopharm, has released findings, which it did on Wednesday with minimal details. Regulators in China have not officially approved any of them.